# Guaifenesin D

NDC: 0536-1333
Generic name: Guaifenesin and Pseudoephedrine Hydrochloride
Labeler / Manufacturer: RUGBY LABORATORIES, INC.
Product type: HUMAN OTC DRUG
Marketing category: Abbreviated NDA (generic)
Dosage form: TABLET, EXTENDED RELEASE
Routes: ORAL
Marketing started: 20220404
Marketing ended: 20270331
FDA application: ANDA212542

## Active ingredients

- GUAIFENESIN: 600 mg/1
- PSEUDOEPHEDRINE HYDROCHLORIDE: 60 mg/1

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"0536-1333"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=0536-1333
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=997946e6-eff0-4c15-8694-020a19c2d336